The association between the expression of each of these proteins with breast cancer molecular characteristics and molecular subtypes (Additional file Table S2), as well as with available specific metabolic biomarkers (HIF1, GLUT1, CAIX and CD147) (Additional file Table S3), was evaluated. This evidence concerns the gene CA9 and breast carcinoma.